CXMT made a blockbuster debut with an IPO that raised 66.6 billion yuan, the largest mainland tech share sale in China’s history, driven by surging memory-chip demand from AI, data-centre expansion, and broader AI infrastructure growth.

Despite the high-profile listing, market watchers note CXMT’s 2025 position as the world’s fourth-largest DRAM maker with about 8% of global shipments, and caution that reaching an additional 4% share by 2028 would still be short of a globally competitive 15% threshold.

CXMT’s listing temporarily sits under regulatory scrutiny as it appears on the Pentagon’s list of Chinese companies with alleged military ties, though such listings do not automatically bar U.S. business dealings.

The article includes standard disclaimers that it is informational and not a buy/sell recommendation, and that the platform’s views may differ from the publisher’s.

The broader market context remains weak for small-caps and tech shares due to global tensions, fund deleveraging, and sector rotation, influencing CXMT’s post-listing performance.

Analysts expect a positive earnings outlook and potential medium-to-long-term stock rebound as the fundamental logic for AI-related chip demand stays intact.

Caution is advised on exit liquidity risk in 2026, with concerns that a downturn in Shanghai could affect broader markets and shift fortunes away from resources and tech microcaps.

Some analysts warned that CXMT’s valuation looked speculative and could constitute a bubble, prompting quick exits by certain investors.

Limited free float around 6.7% could heighten volatility, with risks if AI investment wanes or competitors boost supply.

Macro context touches oil-market movements and broader Asian market dynamics, which shape tech stocks and investor sentiment.

(With inputs from agencies.)